The 2023 Fiasp supply dramas are entering a new phase. We have an opportunity to contribute to the process in the next week. Scroll on and you’ll find details. But first, some background. Or jump ahead if you’re in a hurry…. History recap In June 2019 Fiasp was added to the Australian Pharmaceutical Benefits Scheme …
This article is a general education one, but it’s also reference material for an upcoming discussion on insulin availability. In Australia most insulins have been available in up to three formats: 10 mL vials. Traditionally used for syringe injections and filling pumps. 3 mL pen cartridges. Put into pens for injections. Some people also use …
This is a follow-on from my “Adjunctive therapies” article. If you haven’t read that yet, please do so before proceeding. Here I’m going to talk about a few of the medications that people already take in parallel with insulin use. Not all of them of course (only statins, fibrates, and metformin) but there are other …
As people living with Type 1 Diabetes we’re used to the concepts of dosing ourselves with insulin and how that interacts with food, exercise, and our BG levels. It can be very convoluted, with many subtle factors sometimes having significant effect on our BG. But is the world as straightforward as “only” striving for perfect …
No technical details in today’s article. Just philosophy… I think most people with T1D are familiar with the concept of every day being an experiment. But people do interpret this in different ways. Mad science Some people think of this along the lines of the Muppets’ interpretation, where Bunsen’s experiments always end up in disaster. …
This Saturday is the date for the 2023 Cukrzyca Tech Fest, an online conference with a series of talks about various aspects of diabetes tech. One of the speakers is me! I’m presenting a half-hour session titled “Tuning a closed loop – every day is an experiment“. In case you didn’t know I don’t speak …